Nutritional Interventions for Patients with Melanoma: From Prevention to Therapy—An Update
Marianna Pellegrini(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Simona Bo(University of Turin), Maria Teresa Fierro(University of Turin), Valentina Ponzo(University of Turin), Pietro Quaglino(Department of Medical Sciences), Luca Tonella(University of Turin), Chiara D’Eusebio(University of Turin), Concetta Finocchiaro(University of Catania)
Cited by 15
Related Papers
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
|JAMA Dermatology|2015|452
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
|European Journal of Cancer|2017|449